BCL2 and glioblastoma: The derivative P129 was validated through molecular docking to exhibit high binding affinity with CDK-2. MD simulations confirmed the stability of the complex. Cellular experiments demonstrated that P129 inhibited glioblastoma cell proliferation and migration while inducing apoptosis via the mitochondrial-dependent pathway and downregulating Bcl-2 expression